CLINICAL_TRIALS
trial_result
· 2021-06-29
Clinical Trial Update: Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH) [Phase 3]
Summary
A Phase 3 clinical trial in participants with homozygous familial hypercholesterolemia has completed and results were posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2021-06-29